Actualités

29 novembre 2021

High prevalence of multifocal disease highlighted for paediatric papillary thyroid carcinoma

Research points to a high prevalence of multifocal disease in children with papillary thyroid carcinoma (PTC), with age and tumour stage possible risk factors for this diagnosis. Maisie Shindo, from Oregon Health & Science University in Portland, USA, and colleagues report their findings in JAMA Otolaryngology – Head & Neck Surgery from a cohort study of 212 patients aged up to 18 years who underwent thyroidectomy at one of five US hospitals between 2010 and 2020.

Lire >

22 novembre 2021

Urgences et Covid 19

Retour d’expérience avec le Dr Romain Thevenoud

Lire >

19 novembre 2021

Significant and sustained phase 2 results for maralixibat in Alagille syndrome

The bile acid transport inhibitor maralixibat, given at a higher dose than previously tested, may significantly improve cholestasis in children with Alagille syndrome, shows the phase 2 ICONIC trial.

Lire >

10 novembre 2021

Covid-19 et impact sur l’activité en psychiatrie

Portrait du Dr Jean Victor Blanc

Lire >

8 novembre 2021

Plasma GFAP ‘a sensitive biomarker’ for early amyloid-β pathology

Plasma glial fibrillary acidic protein (GFAP) outperforms its cerebrospinal fluid (CSF) counterpart in the detection of amyloid-β (Aβ) pathology even in the early stages of Alzheimer’s disease (AD), indicates a cross-sectional study.

Lire >

2 novembre 2021

Intranasal oxytocin fails to improve social functioning of autistic children

Intranasal oxytocin therapy did not improve the social or cognitive functioning of children and adolescents with autism in a randomised trial published in The New England Journal of Medicine.

Lire >

25 octobre 2021

Study identifies new subtypes of pSS, SLE based on immunological profiles

Immunological profiles could be used to categorize patients with primary Sjögren’s Syndrome (pSS) or systemic lupus erythematosus (SLE) into distinct subgroups irrespective of diagnosis, suggests UK research published in Arthritis & Rheumatology.

Lire >

18 octobre 2021

Hearing loss protection recommendations made for paediatric CNS, head and neck cancer patients

The risk of high-frequency hearing loss (HL) in children undergoing cancer treatment to the central nervous system (CNS) or the head and neck could be reduced by minimising doses of radiation to the cochlea and limiting cumulative doses of cisplatin or carboplatin, Canadian researchers say.

Lire >

13 octobre 2021

Methylphenidate offers apathy treatment hope for Alzheimer’s disease patients

medwireNews: Methylphenidate is effective for the treatment of apathy in patients with Alzheimer’s disease (AD), suggest study findings published in JAMA Neurology.

Lire >

1 octobre 2021

Grossesse et récidive de cancer du sein, des données scientifiques rassurantes

D’après une équipe de chercheurs italiens, parmi les survivantes du cancer du sein, il n'y avait pas d'augmentation du risque de récidive de cancer du sein après une grossesse. Un risque souvent évoqué par les équipes médicales qui n’est pas toujours fondé.

Lire >

Pages